Iceland vs Sur: New cases tested for RR-/MDR-TB
Iceland
100.0%
in 2024
Sur
97.0%
in 2024
Iceland rank
1st
Sur rank
1st
New cases tested for RR-/MDR-TB over time
- Iceland
- Sur
How they compare
Iceland currently reports 100.0% against 97.0% in Sur, a difference of 3.0%.
The two have swapped places 6 times across 15 shared years of data; in 2005 it was Iceland ahead.
Iceland ranks 1st and Sur ranks 1st of 192 countries.
Across the 3 decades both report, Iceland averaged higher in 2 and Sur in 1.
Head to head by decade
| Decade | Iceland | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 32.2% | 67.8% | Iceland |
| 2010s | 92.2% | 62.2% | 30.0% | Iceland |
| 2020s | 50.0% | 96.5% | 46.5% | Sur |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Iceland or Sur?
- Iceland, at 100.0% against 97.0% in Sur as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Iceland and Sur?
- 3.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Sur?
- 15 years are reported by both, from 2005 to 2024.
- How do Iceland and Sur rank globally for new cases tested for rr-/mdr-tb?
- Iceland ranks 1st and Sur ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.